MarketInOut Stock Screener Log In | Sign Up
 

GSK Plc ADR

NYSE • Healthcare • Drug Manufacturers - General • Quote as of 05/11/2026 16:00
GSK Plc ADR stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNYSE
Market Capitalization101,199 mln
Float1,996 mln
Earnings Date08/05/2026

EPS

3.86
Solid

P / E

12.90
Fair value

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-2.43
Borderline

1-Year Forecast

57.65
Attractive

Relative Strength

8 / 100
Severely lagging

Business Description

GSK is a global healthcare company based in London that develops, manufactures, and sells vaccines, specialty medicines, and general medicines to help prevent and treat a wide range of diseases. Its product portfolio covers areas such as cancer, HIV, respiratory conditions, and infectious diseases, as well as vaccines protecting against illnesses like shingles, meningitis, and hepatitis. The company also partners with other organizations to advance new treatments, including mRNA vaccines and therapies for tuberculosis. Originally founded in 1715 and formerly known as GlaxoSmithKline, GSK operates across the United Kingdom, the United States, and many other countries worldwide.

Key Fundamentals

EPS3.86
P/E12.90
ROE37.04
RPS21.55
ROIC14.15
ROA9.63
Interest Cover12.16
EBITDA, mln14,128
EV / EBITDA8.76
EV / EBIT11.31
Revenue, mln44,095
EV / Revenue2.81

Financial Strength

Altman Z-Score2.13
Piotroski F-Score 8 / 9
Beneish M-Score-2.43
Price to Intrinsic Value1.27
1-Year Target Price57.65
Shiller PE Ratio12.73
Short Ratio3.67
Short % of Float0.77

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -2.14% 17 / 100   
1 Month -14.43% 3 / 100   
2 Months -4.32% 21 / 100   
6 Months 7.51% 50 / 100   
1 Year 40.43% 77 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us